Literature DB >> 27296838

Oxidative stress and altered lipid metabolism in Friedreich ataxia.

Jordi Tamarit1, Èlia Obis1, Joaquim Ros2.   

Abstract

Friedreich ataxia is a genetic disease caused by the deficiency of frataxin, a mitochondrial protein. Frataxin deficiency impacts in the cell physiology at several levels. One of them is oxidative stress with consequences in terms of protein dysfunctions and metabolic alterations. Among others, alterations in lipid metabolism have been observed in several models of the disease. In this review we summarize the current knowledge of the molecular basis of the disease, the relevance of oxidative stress and the therapeutic strategies based on reduction of mitochondrial reactive oxygen species production. Finally, we will focus the interest in alterations of lipid metabolism as a consequence of mitochondrial dysfunction and describe the therapeutic approaches based on targeting lipid metabolism.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Friedreich ataxia; Iron; Lipid metabolism; Mitochondria; Oxidative stress

Mesh:

Substances:

Year:  2016        PMID: 27296838     DOI: 10.1016/j.freeradbiomed.2016.06.007

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  20 in total

1.  Inducible and reversible phenotypes in a novel mouse model of Friedreich's Ataxia.

Authors:  Vijayendran Chandran; Kun Gao; Vivek Swarup; Revital Versano; Hongmei Dong; Maria C Jordan; Daniel H Geschwind
Journal:  Elife       Date:  2017-12-19       Impact factor: 8.140

2.  Transcriptional profiling of isogenic Friedreich ataxia neurons and effect of an HDAC inhibitor on disease signatures.

Authors:  Jiun-I Lai; Daniel Nachun; Lina Petrosyan; Benjamin Throesch; Erica Campau; Fuying Gao; Kristin K Baldwin; Giovanni Coppola; Joel M Gottesfeld; Elisabetta Soragni
Journal:  J Biol Chem       Date:  2018-12-14       Impact factor: 5.157

3.  Effects of tocotrienol supplementation in Friedreich's ataxia: A model of oxidative stress pathology.

Authors:  Alessandra Bolotta; Antonella Pini; Provvidenza M Abruzzo; Alessandro Ghezzo; Alessandra Modesti; Tania Gamberi; Carla Ferreri; Francesca Bugamelli; Filippo Fortuna; Silvia Vertuani; Stefano Manfredini; Cinzia Zucchini; Marina Marini
Journal:  Exp Biol Med (Maywood)       Date:  2019-12-03

4.  Nitric oxide prevents Aft1 activation and metabolic remodeling in frataxin-deficient yeast.

Authors:  David Alsina; Joaquim Ros; Jordi Tamarit
Journal:  Redox Biol       Date:  2017-09-06       Impact factor: 11.799

Review 5.  Drosophila melanogaster Models of Friedreich's Ataxia.

Authors:  P Calap-Quintana; J A Navarro; J González-Fernández; M J Martínez-Sebastián; M D Moltó; J V Llorens
Journal:  Biomed Res Int       Date:  2018-04-05       Impact factor: 3.411

Review 6.  Iron in Friedreich Ataxia: A Central Role in the Pathophysiology or an Epiphenomenon?

Authors:  David Alsina; Rosa Purroy; Joaquim Ros; Jordi Tamarit
Journal:  Pharmaceuticals (Basel)       Date:  2018-09-19

Review 7.  Impact of Drosophila Models in the Study and Treatment of Friedreich's Ataxia.

Authors:  Véronique Monnier; Jose Vicente Llorens; Juan Antonio Navarro
Journal:  Int J Mol Sci       Date:  2018-07-07       Impact factor: 5.923

8.  Frataxin-deficient neurons and mice models of Friedreich ataxia are improved by TAT-MTScs-FXN treatment.

Authors:  Elena Britti; Fabien Delaspre; Anat Feldman; Melissa Osborne; Hagar Greif; Jordi Tamarit; Joaquim Ros
Journal:  J Cell Mol Med       Date:  2017-10-05       Impact factor: 5.310

Review 9.  Role of Mesenchymal Stem Cells in Counteracting Oxidative Stress-Related Neurodegeneration.

Authors:  Cristina Angeloni; Martina Gatti; Cecilia Prata; Silvana Hrelia; Tullia Maraldi
Journal:  Int J Mol Sci       Date:  2020-05-07       Impact factor: 5.923

Review 10.  Transcriptional regulators of redox balance and other homeostatic processes with the potential to alter neurodegenerative disease trajectory.

Authors:  Scott W Burnside; Giles E Hardingham
Journal:  Biochem Soc Trans       Date:  2017-11-17       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.